United States · Biotechnology startup
United States · NeuroLutions
The Company seeks to develop a revolutionary platform of devices, based on Brain Computer Interface (BCI) technology
Funding reportedLast round: Undisclosed round
Follow NeuroLutions and see its new rounds in your feed.Start following
What company datasets say NeuroLutions raised
Funding, as reported
Reported in all$27Min dollars
Rounds3
Last roundUndisclosed round
Last round dateJul 2018
Investors listed5
SEC Form D$27M sold, 1 filing, last Mar 2025
Founders and team
From NeuroLutions's own website: 12 on the team.
- Leo PetrossianChief Executive Officer
- Andy SchultzChief Commercial Officer
- Javad SeyedzadehChief Operations Officer
- Kirsten CarrollChief Marketing Officer
- Nabeel AhmedChief Financial Officer
- Seth WilkChief Innovation Officer
- Bret ChristensenBoard Member
- Fred KhosraviChairman of the Board
- Kevin ReillyBoard Member
- Marshal LinderBoard Member
- Michael LevitzBoard Member
- William TaiBoard Member
On 3 portfolio pages
Investors who name them
Each firm lists NeuroLutions on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put NeuroLutions in front of investors. Or tell us what we have wrong.